Document:

Exhibit
      10.11

    SECOND
      AMENDED AND RESTATED SUBSCRIPTION AGREEMENT

     

      SECOND
        AMENDED AND RESTATED SUBSCRIPTION AGREEMENT (this “Agreement”)
        made
        as of this 14th
        day of
        May, 2007 for the benefit of TransTech Services Partners Inc., a Delaware
        corporation (the “Company”),
        having its principal place of business at 445 Fifth Avenue, Suite 30H, New
        York,
        New York, and by the person or entity listed on the signature page hereto
        under
        the heading “Subscriber” (the “Subscriber”).

     

    WHEREAS,
      the Company and the Subscriber entered into a Subscription Agreement (the
“Original
      Subscription Agreement”),
      dated
      as of September 18, 2006, pursuant to which the Subscribers agreed to purchase
      Units (as defined in the Original Subscription Agreement) of the
      Company;

     

      WHEREAS,
        the Company and the Subscriber entered
        into an Amended and Restated Subscription Agreement (the “Amended
        and Restated Subscription Agreement”),  dated as of February 14, 2007,
        pursuant to which the Subscriber agreed to purchase 1,025,000
        warrants;

     

    WHEREAS,
      the parties intend this Agreement to modify, amend and supersede to Original
      Subscription Agreement and the Amended and Restated Subscription
      Agreement;

    

      WHEREAS,
        the Company desires to sell an aggregate of 1,191,667 warrants (the
“Warrants”)
        to
        purchase 1,191,667 shares of the Company’s common stock, par value $.0001 per
        share (the “Common
        Stock”),
        for a
        purchase price of $1.20 per Warrant (i.e.,
        an
        aggregate purchase price of $1,430,000); and

     

    WHEREAS,
      the offer and sale of the Warrants (the “Offering”)
      are
      being made in reliance upon the provisions of Regulation D (“Regulation
      D”)
      promulgated by the Securities and Exchange Commission (the “SEC”)
      under
      the Securities Act of 1933, as amended (the “Securities
      Act”);

     

    NOW,
      THEREFORE, for and in consideration of the premises and the mutual covenants
      hereinafter set forth, the Company and the Subscriber do hereby agree as
      follows

     

    1.  Agreement
      to Subscribe

     

    1.1  Purchase
      and
      Issuance of the Warrants.
      The
      Subscriber is hereby subscribing for the number of Warrants indicated on the
      signature page hereto by the caption, “Number of Warrants Being Subscribed” (the
“Subscriber's
      Warrants”),
      which
      Subscriber’s Warrants will be issued to the Subscriber, or his affiliates or
      designees. The aggregate purchase price for the Subscriber’s Warrants (the
“Purchase
      Price”)
      is
      indicated on the signature page hereto by the caption, “Purchase Price”.

     

    1.2  Delivery
      of the Purchase Price.
      Upon
      execution of this Agreement, the Subscriber is hereby bound to fulfill his
      or
      its obligations hereunder and hereby irrevocably commits to deliver to the
      Company on the date of Closing (as hereinafter defined) the Purchase Price
      by
      bank check, wire transfer or such other form of payment as shall be acceptable
      to the Company, in its sole and absolute discretion, at the Closing. Any such
      check delivered to the Company shall be made payable to the order of “TransTech
      Services Partners Inc.” The Company shall deposit the Purchase Price into the
      trust account described in the registration statement (and any amendment
      thereto) (the “Registration
      Statement”)
      filed
      with the SEC relating to the Company’s proposed initial public offering of up to
      5,175,000 units of Common Stock and the Warrants (the “IPO“).
      Subject to Section 5, the certificates for the Warrants comprising the
      Subscriber’s Warrants shall be delivered to the Purchaser promptly following the
      Closing.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    1.3  Closing.
      The
      closing of the Offering (the “Closing“)
      shall
      take place at the offices of the Company prior to the effective date of the
      IPO.

     

    2.  Representations
      and Warranties of the Subscriber

     

    The
      Subscriber represents and warrants to the Company that:

     

    2.1  No
      Government Recommendation or Approval.
      The
      Subscriber understands that no U.S. federal or state agency or similar agency
      of
      any other country, has passed upon or made any recommendation or endorsement
      of
      the Company or the Offering of the Warrants. 

     

    2.2  Investment
      Representations.
      The
      Subscriber is purchasing the Warrants for its or his own account without a
      view
      to any distribution thereof in violation of the Securities Act. The Subscriber
      represents that it (he) (i) is an “Accredited Investor” as that term is defined
      under Rule 501 under the Securities Act; (ii) has no contract, undertaking,
      agreement or arrangement with any person to sell, transfer or pledge to such
      person or anyone else the Warrants, the shares of Common Stock issuable upon
      exercise of the Warrants (the “Warrant
      Shares”
and
      together with the Warrants, the “Securities”),
      or
      any part thereof; (iii) has sufficient knowledge and experience in business
      matters to evaluate the merits and risks of the investment; (iv) has no need
      for
      liquidity of its or his investment and (v) would be able to bear the economic
      risk of a complete loss of its or his proposed investment hereunder. The
      Subscriber acknowledges that none of the Securities have been registered by
      the
      Company under the Securities Act and agrees that the Securities may only be
      transferred if registered under the Securities Act or pursuant to an exemption
      from such registration requirements. The Subscriber understands that Rule 144
      promulgated under the Securities Act is not presently available with respect
      to
      the Securities. 

     

    The
      Subscriber acknowledges, agrees and covenants that it (he) will not engage
      in
      hedging transactions with regard to the Securities, unless in compliance with
      the Securities Act. The Subscriber agrees that if any transfer of the Warrants
      or any interest therein is proposed to be made, as a condition precedent to
      such
      transfer, the Subscriber may be required to deliver to the Company an opinion
      of
      a counsel satisfactory to the Company.

     

    2.3  Independent
      Investigation.
      The
      Subscriber, in making the decision to purchase the Warrants, has relied upon
      an
      independent investigation of the Company and has not relied upon any information
      or representations made by any third parties or upon any oral or written
      representations or assurances from the Company, its officers, directors or
      employees or any other representatives or agents of the Company, other than
      as
      set forth in this Agreement. The Subscriber is familiar with the business,
      operations and financial condition of the Company and has had an opportunity
      to
      ask questions of, and receive answers from, the Company’s officers and directors
      concerning the Company and the terms and conditions of the offering of the
      Warrants and has had full access to such other information concerning the
      Company as the Subscriber has requested.

     

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

     

    2.4  Authority.
      This
      Agreement has been validly authorized, executed and delivered by the Subscriber
      and is a valid and binding agreement enforceable against the Subscriber in
      accordance with its terms, subject to the general principles of equity and
      to
      bankruptcy or other laws affecting the enforcement of creditors' rights
      generally. The execution, delivery and performance of this Agreement by the
      Subscriber does not and will not conflict with, violate or cause a breach of
      any
      agreement, contract or instrument to which the Subscriber is a
      party.

     

    2.5  No
      Legal Advice from Company.
      The
      Subscriber acknowledges that he or it has had the opportunity to review this
      Agreement and the transactions contemplated by this Agreement and the other
      agreements entered into between the parties hereto with the Subscriber's own
      legal counsel and investment and tax advisors. Except for any statements or
      representations of the Company made in this Agreement and the other agreements
      entered into between the parties hereto, the Subscriber is relying solely on
      such counsel and advisors and not on any statements or representations of the
      Company or any of its representatives or agents for legal, tax or investment
      advice with respect to this investment, the transactions contemplated by this
      Agreement or the securities laws of any jurisdiction.

     

    2.6  Reliance
      on Representations and Warranties.
      The
      Subscriber understands that the Warrants are being offered and sold to the
      Subscriber in reliance on specific provisions of U.S. federal and state
      securities laws and that the Company is relying upon the truth and accuracy
      of
      the representations, warranties, agreements, acknowledgments and understandings
      of the Subscriber set forth in this Agreement in order to determine the
      applicability of such provisions.

     

    2.7  No
      Advertisements.
      The
      undersigned is not subscribing for the Warrants as a result of or subsequent
      to
      any advertisement, article, notice or other communication published in any
      newspaper, magazine, or similar media or broadcast over television or radio,
      or
      presented at any seminar or meeting.

     

    2.8  Legend.
      The
      Subscriber acknowledges and agrees that the Warrants, and when issued the
      Warrant Shares, shall bear restricted legends (the “Legends”),
      in
      the form and substance as set forth in Section 4 hereof, prohibiting the offer,
      sale, pledge or transfer of the securities, except (i) pursuant to an effective
      registration statement filed under the Securities Act, (ii) pursuant to an
      exemption from registration provided by Rule 144 under the Securities Act (if
      available), or (iii) pursuant to any other exemption from the registration
      requirements of the Securities Act. 

     

    3.  Representations
      and Warranties of the Company

     

    The
      Company represents and warrants to the Subscriber that:

     

    3.1  Valid
      Issuance of Capital Stock.
      The
      total number of shares of all classes of capital stock which the Company has
      authority to issue is 20,918,920 shares of Common Stock and 1,000,000 shares
      of
      preferred stock. As of the date hereof, the Company has 1,125,000 shares of
      Common Stock after giving effect to the Company’s 3 for 4 reverse stock split
      and its 0.972973 for 1 reverse stock split and no shares of preferred stock
      issued and outstanding. All of the issued shares of capital stock of the Company
      have been duly authorized, validly issued, and are fully paid and
      non-assessable.

     

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

     

    3.2  Organization
      and Qualification.
      The
      Company is a corporation duly incorporated and existing in good standing under
      the laws of the state of Delaware and has the requisite corporate power to
      own
      its properties and assets and to carry on its business as now being
      conducted.

     

    3.3  Authorization;
      Enforcement.
      (i) The
      Company has the requisite corporate power and authority to enter into and
      perform its obligations under this Agreement and to issue the Securities in
      accordance with the terms hereof, (ii) the execution, delivery and performance
      of this Agreement by the Company and the consummation by it of the transactions
      contemplated hereby have been duly authorized by all necessary corporate action,
      and no further consent or authorization of the Company or its Board of Directors
      or stockholders is required, and (iii) this Agreement constitutes valid and
      binding obligations of the Company enforceable against the Company in accordance
      with its terms, except as such enforceability may be limited by applicable
      bankruptcy, insolvency, fraudulent conveyance, moratorium, reorganization,
      or
      similar laws relating to, or affecting generally the enforcement of, creditors'
      rights and remedies or by equitable principles of general application and except
      as enforcement of rights to indemnity and contribution may be limited by federal
      and state securities laws or principles of public policy.

     

    3.4  No
      Conflicts.
      The
      execution, delivery and performance of this Agreement and the consummation
      by
      the Company of the transactions contemplated hereby do not (i) result in a
      violation of the Company's Third Amended and Restated Certificate of
      Incorporation or By-laws or (ii) conflict with, or constitute a default under
      any agreement, indenture or instrument to which the Company is a party. Other
      than any SEC or state securities filings which may be required to be made by
      the
      Company subsequent to the Closing, and any registration statement which may
      be
      filed pursuant thereto, the Company is not required under federal, state or
      local law, rule or regulation to obtain any consent, authorization or order
      of,
      or make any filing or registration with, any court or governmental agency or
      self-regulatory entity in order for it to perform any of its obligations under
      this Agreement or issue the Securities in accordance with the terms hereof.
      

     

    4.  Legends;
      Denominations

     

    4.1  Legends.
      The
      Company will issue the Warrants, and when issued the Warrant Shares, purchased
      by the Subscriber in the name of the Subscriber and in such denominations to
      be
      specified by the Subscriber prior to the Closing. The Securities will bear
      the
      following Legends and appropriate "stop transfer" instructions:

     

    THESE
      SECURITIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT
      OF
      1933, AS AMENDED (THE “SECURITIES ACT”), AND THESE SECURITIES MAY NOT BE
      OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT (A) PURSUANT TO AN
      EFFECTIVE REGISTRATION STATEMENT FILED UNDER THE SECURITIES ACT, (B) PURSUANT
      TO
      AN EXEMPTION FROM REGISTRATION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT
      (IF
      AVAILABLE) OR (C) PURSUANT TO ANY OTHER EXEMPTION FROM THE REGISTRATION
      REQUIREMENTS OF THE SECURITIES ACT, IN EACH CASE IN ACCORDANCE WITH ANY
      APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR ANY OTHER
      JURISDICTION. HEDGING TRANSACTIONS INVOLVING THESE SECURITIES MAY NOT BE
      CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT.

     

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

     

    THESE
      SECURITIES ARE SUBJECT TO A LOCK UP AGREEMENT, WHICH IS FILED WITH THE COMPANY’S
      CORPORATE BOOKS AND RECORDS.

     

    4.2  Subscriber's
      Compliance.
      Nothing
      in this Section 4 shall affect in any way the Subscriber's obligations and
      agreement to comply with all applicable securities laws upon resale of the
      Securities.

     

    4.3  Company’s
      Refusal to Register Transfer of Securities.
      The
      Company shall refuse to register any transfer of the Securities, not made in
      accordance with (i) pursuant to an effective registration statement filed under
      the Securities Act, or (ii) pursuant to an available exemption from the
      registration requirements of the Securities Act.

     

    5.  Lock
      up.

     

    The
      Subscriber shall, as specified in a Letter Agreement which the Company, Cowen
      and Company, LLC and Maxim Group LLC will enter into with the Subscriber, lock
      up the Subscriber’s Warrants for a period commencing on the date of the Letter
      Agreement and ending on the earlier of (i) the consummation of a Business
      Combination or (ii) the Company’s dissolution and liquidation. As used herein, a
“Business
      Combination”
      shall
      mean any acquisition by merger, capital stock exchange, asset acquisition,
      stock
      purchase or other similar business combination consummated by the Company with
      one or more small- to mid-market U.S. and/or European based operating companies
      engaged in the delivery of Information Technology and Information Technology
      Enabled Services (ITES), Business Process Outsourcing (BPO) and/or Knowledge
      Process Outsourcing (KPO), whose operations are particularly suitable for
      operational and productivity improvements, which would include leveraging
      delivery centers located in offshore countries such as India (as described
      more
      fully in the Registration Statement).

     

    6.  Waiver
      of Liquidation Distributions. 

     

    In
      connection with the Subscriber’s Warrants purchased pursuant to this Agreement,
      the Subscriber hereby waives any and all right, title, interest or claim of
      any
      kind in or to any liquidating distributions by the Company in the event of
      a
      liquidation of the Company upon the Company's failure to timely complete a
      Business Combination. For purposes of clarity, in the event the Subscriber
      purchases shares of Common Stock in the IPO or in the aftermarket such shares
      shall be eligible to receive any liquidating distributions by the Company.
      The
      Subscriber shall have no conversion rights (as described in the Registration
      Statement) in connection with a Business Combination.

     

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

     

    7.  Rescission
      Right Waiver and Indemnification

     

    7.1  The
      Subscriber understands and acknowledges that an exemption from the registration
      requirements of the Securities Act requires that there be no general
      solicitation of purchasers of the Warrants. In this regard, if the offering
      of
      the units in the Company’s initial public offering were deemed to be a general
      solicitation with respect to the Subscriber’s Warrants, the offer and sale of
      such Warrants may not be exempt from registration and, if not, the Subscriber
      may have a right to rescind its purchases of the Subscriber’s Warrants. In order
      to facilitate the completion of the placement contemplated hereby and in order
      to protect the Company, its stockholders and the trust account described in
      the
      Registration Statement from claims that may adversely affect the Company or
      the
      interests of its stockholders, the Subscriber hereby agrees to waive, to the
      maximum extent permitted by applicable law, any claims, right to sue or rights
      in law or arbitration, as the case may be, to seek rescission of its purchase
      of
      the Warrants. The Subscriber acknowledges and agrees that this waiver is being
      made in order to induce the Company to sell the Warrants to the Subscriber.
      The
      Subscriber agrees that the foregoing waiver of rescission rights shall apply
      to
      any and all known or unknown actions, causes of action, suits, claims, or
      proceedings (collectively, “Claims”)
      and
      related losses, costs, penalties, fees, liabilities and damages, whether
      compensatory, consequential or exemplary, and expenses in connection therewith,
      including reasonable attorneys’ and expert witness fees and disbursements and
      all other expenses reasonably incurred in investigating, preparing or defending
      against any Claims, whether pending or threatened, in connection with any
      present or future actual or asserted right to rescind the purchase of the
      Warrants hereunder or relating to the purchase of the Warrants and the
      transactions contemplated hereby.

     

    7.2  The
      Subscriber agrees not to seek recourse against the trust account described
      in
      the Registration Statement for any reason whatsoever in connection with its
      purchase of the Warrants or any Claim that may arise now or in the
      future.

     

    7.3  The
      Subscriber acknowledges and agrees that the stockholders of the Company are
      and
      shall be third-party beneficiaries of the foregoing provisions of this
      Agreement.

     

    7.4  The
      Subscriber agrees that to the extent any waiver of rights under this Section
      7
      is ineffective as a matter of law, the Subscriber has offered such waiver for
      the benefit of the Company as an equitable right that shall survive any
      statutory disqualification or bar that applies to a legal right. The Subscriber
      acknowledges the receipt and sufficiency of consideration received from the
      Company hereunder in this regard.

     

    8.  Registration
      Rights. 

     

    The
      Subscriber shall have registration rights with respect to the Securities
      pursuant to the terms of a Registration Rights Agreement to be entered into
      among the Company and certain of its security holders (including the
      Subscriber).

     

    
      
        
        

      

      
        6

        
          

        

      

      
        
        

      

    

     

    9.  Governing
      Law; Jurisdiction; Waiver of Jury Trial

     

    This
      Agreement shall be governed by and construed in accordance with the laws of
      the
      State of New York applicable to contracts made and to be performed wholly within
      said State, without giving effect to the conflict of laws principles thereof.
      The Subscriber irrevocably submits to the exclusive jurisdiction of the courts
      of the State of New York located in New York County and the United District
      Court for the Southern District of New York. The parties hereto hereby waive
      any
      right to a jury trial in connection with any litigation pursuant to this
      Agreement and the transactions contemplated hereby.

     

    10.  Assignment;
      Entire Agreement; Amendment

     

    10.1  Assignment.
      Neither
      this Agreement nor any rights hereunder may be assigned by any party to any
      other person other than by the Subscriber to a person agreeing to be bound
      by
      the terms hereof. 

     

    10.2  Entire
      Agreement.
      This
      Agreement sets forth the entire agreement and understanding between the parties
      as to the subject matter thereof and merges and supersedes all prior
      discussions, agreements and understandings of any and every nature among
      them.

     

    10.3  Amendment.
      Except
      as expressly provided in this Agreement, neither this Agreement nor any term
      hereof may be amended, waived, discharged or terminated other than by a written
      instrument signed by the party against whom enforcement of any such amendment,
      waiver, discharge, or termination is sought.

     

    10.4  Binding
      Upon Successors.
      This
      Agreement shall be binding upon and inure to the benefit of the parties hereto
      and to their respective heirs, legal representatives, successors and permitted
      assigns. 

     

    11.  Notices;
      Indemnity

     

    11.1  Notices.
      Unless
      otherwise provided herein, any notice or other communication to a party
      hereunder shall be sufficiently given if in writing and personally delivered
      or
      sent by facsimile with copy sent in another manner herein provided or sent
      by
      courier (which for all purposes of this Agreement shall include Federal Express
      or other recognized overnight courier) or mailed to said party by certified
      mail, return receipt requested, at its address provided for herein or such
      other
      address as either may designate for itself in such notice to the other and
      communications shall be deemed to have been received when delivered personally,
      on the scheduled arrival date when sent by next day or 2-day courier service,
      or
      if sent by facsimile upon receipt of confirmation of transmittal or, if sent
      by
      mail, then three days after deposit in the mail.

     

    11.2  Indemnification.
      Each
      party shall indemnify the other against any loss, cost or damages (including
      reasonable attorney's fees and expenses) incurred as a result of such party's
      breach of any representation, warranty, covenant or agreement in this
      Agreement.

     

    
      
        
        

      

      
        7

        
          

        

      

      
        
        

      

    

     

    12.  Counterparts

     

    This
      Agreement may be executed in any number of counterparts, each of which shall
      be
      enforceable against the parties actually executing such counterparts, and all
      of
      which together shall constitute one instrument.

     

    13.  Survival;
      Severability

     

    13.1  Survival.
      The
      representations, warranties, covenants and agreements of the parties hereto
      shall survive the Closing. 

     

    13.2  Severability.
      In the
      event that any provision of this Agreement becomes or is declared by a court
      of
      competent jurisdiction to be illegal, unenforceable or void, this Agreement
      shall continue in full force and effect without said provision; provided that
      no
      such severability shall be effective if it materially changes the economic
      benefit of this Agreement to any party.

     

    14.  Titles
      and Subtitles

     

    The
      titles and subtitles used in this Agreement are used for convenience only and
      are not to be considered in construing or interpreting this
      Agreement.

     

    Name
      of
      the Subscriber: TSP Ltd.

     

      Number
        of
        Warrants Being Subscribed: 1,191,667

    

      Aggregate
        Purchase Price: U.S. $1,430,000

     

    Date
      of
      Subscription: _______________, 2007

    

    Place
      of
      Residency and/or Principal Place of Business:

    

    c/o
      Canon’s Court 

    22
      Victoria Street

    Hamilton
      HM12 Bermuda

    Telephone:_________________________

    Fax:_______________________________

    
      
        
        

      

      
        8

        
          

        

      

      
        
        

      

    

    This
      subscription is accepted by the Company on the 14th
      day of
      February, 2007.

     

    
      	
               

            	 	 
	 	TRANSTECH SERVICES PARTNERS
              INC.
	 
 	 
 	 
 
	 	By:  	/s/ 
Suresh
              Rajpal
	 	
              

              Name:
                Suresh Rajpal

              Title:
                Chief Executive Officer

            
	 	
            

    

    
      	 	 	 
	 	
              SUBSCRIBER:

               

              TSP Ltd.

            
	 
 	 
 	 
 
	 	By:  	/s/ LM
              Singh 
	 	
              
Name:
              LM Singh
	 	
              Title:
                Vice President and Director

            

    

    

    

    
      
        
        

      

      
        9Exhibit
      10.1 

    

    WARRANT
      AGREEMENT

     

    WARRANT
      AGREEMENT, dated
      as
      of May 10, 2007 (this “Agreement”),
      between DOV
      PHARMACEUTICAL, INC.,
      a
      Delaware corporation, with offices at 150 Pierce Street, Somerset, NJ 08873
      (the
“Company”),
      and
CONTINENTAL
      STOCK TRANSFER & TRUST COMPANY,
      with
      offices at 17 Battery Place, New York, NY 10004 (the “Warrant
      Agent”).

     

    W
      I T N E S S E T H:

     

    WHEREAS,
      the
      Company currently contemplates distributing or otherwise delivering number
      up to
      30,000,000 Warrants (“Warrants”)
      to
      holders of the Company’s common stock, par value $0.0001 per share
      (“Common
      Stock”),
      each
      Warrant evidencing the right of the holder thereof to purchase one share of
      Common Stock of the Company for $0.523, subject to adjustment as described
      herein; 

     

    WHEREAS,
      the
      Company will distribute Warrants to purchase 11 shares of Common Stock for
      each
      10 shares of Common Stock held by a holder of Common Stock.

     

    WHEREAS,
      the
      Company desires to have the Warrant Agent act on behalf of the Company, and
      the
      Warrant Agent is willing to so act, in connection with the issuance,
      registration, transfer, exchange, redemption and exercise of the Warrants;
      

     

    WHEREAS,
      the
      Company desires to provide for the form and provisions of the Warrants, the
      terms upon which they shall be issued and exercised, and the respective rights,
      limitation of rights and immunities of the Company, the Warrant Agent and the
      holders of the Warrants; and 

     

    WHEREAS,
      all
      acts and things have been done and performed which are necessary to make the
      Warrants, when executed on behalf of the Company and countersigned by or on
      behalf of the Warrant Agent, as provided herein, the valid, binding and legal
      obligations of the Company, and to authorize the execution and delivery of
      this
      Agreement.

    

    NOW,
      THEREFORE,
      in
      consideration of the premises, representations and warranties and the mutual
      covenants and agreements contained herein and other good, valuable and
      sufficient consideration, the receipt of which is hereby acknowledged, the
      Parties, intending to be legally bound, agree as follows:

     

     

    1.     Appointment
      of Warrant Agent.  The
      Company hereby appoints the Warrant Agent to act as agent for the Company
      relating to the Warrants in accordance with the terms and conditions of this
      Agreement, and the Warrant Agent hereby accepts such appointment and agrees
      to
      act in accordance with such terms and conditions.

     

    2.     Warrants..

     

    2.1.     Form
      of Warrant.
      Each
      Warrant shall be in substantially the form of Exhibit
      A
      hereto,
      the provisions of which are incorporated herein. Each Warrant shall be signed
      by, or bear the facsimile signature of, the Chief Executive Officer and either
      the President, Vice President of Finance or Secretary of the Company and shall
      bear a facsimile of the Company’s seal. If the person whose facsimile signature
      has been placed upon any Warrant shall have ceased to serve in the capacity
      in
      which such person signed the Warrant before such Warrant is issued, it may
      be
      issued with the same effect as if he or she had not ceased to be such at the
      date of issuance.

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    2.2.     Effect
      of Countersignature.
      Unless
      and until countersigned by the Warrant Agent pursuant to this Agreement, a
      Warrant shall be invalid and of no effect and may not be exercised by the holder
      thereof. Such signature by the Warrant Agent upon any Warrant executed by the
      Company shall be conclusive evidence that such Warrant Certificate has been
      duly
      issued under the terms of this Agreement.

     

    2.3.     Registration.

     

    2.3.1     Warrant
      Register.
      The
      Warrant Agent shall maintain books (the “Warrant
      Register”)
      for
      the registration of original issuance and the transfer of Warrants. Upon the
      initial issuance of Warrants, the Warrant Agent shall issue and register such
      Warrants in the names of holders, in such denominations and otherwise in
      accordance with instructions delivered to the Warrant Agent by the
      Company.

     

    2.3.2     Registered
      Holder.
      Prior
      to due presentment for registration of transfer of any Warrant, the Company
      and
      the Warrant Agent may deem and treat the person in whose name such Warrant
      shall
      be registered upon the Warrant Register (the “registered
      holder”)
      as the
      absolute owner of such Warrant (notwithstanding any notation of ownership or
      other writing on such Warrant made by anyone other than the Company or the
      Warrant Agent) for the purpose of any exercise thereof and for all other
      purposes, and neither the Company nor the Warrant Agent shall be affected by
      any
      notice to the contrary.

     

     

    3.     Terms
      and Exercise of Warrants..

     

    3.1.     Warrant
      Price.
      Each
      Warrant shall, when countersigned by the Warrant Agent, entitle the registered
      holder thereof, subject to the provisions of such Warrant and of this Agreement,
      to purchase from the Company the number of shares of Common Stock stated
      therein, at the price of $0.523 per whole share, subject to the adjustments
      provided in Section 4 and in the proviso below in this Section 3.1. The term
      “Warrant
      Price”,
      as
      used in respect of a Warrant, refers to the price per share at which Common
      Stock may be purchased at the time such Warrant is exercised. 

     

    3.2.     Duration
      of Warrants.
      A
      Warrant may be exercised only during the period (the “Exercise
      Period”)
      commencing on July 1, 2007, but subject to Section 3.3.3 below regarding an
      effective registration statement under the Securities Act of 1933, as amended
      (the “Securities
      Act”),
      and
      terminating at 5:00 p.m., New York time, on the earliest to occur of (x)
      December 31, 2009, and (y) the date fixed for redemption of Warrants as provided
      in Section 6.2 (the “Expiration
      Date”).
      Except with respect to the right to receive the Redemption Price (as set forth
      in Section 6), each Warrant not exercised on or before the Expiration Date
      shall
      become void, and all rights thereunder and all rights in respect thereof under
      this Agreement shall expire. 

     

     

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

     

    3.3.     Exercise
      of Warrants.
      

     

    3.3.1     Payment.
      Subject
      to the provisions of such Warrant and this Agreement, a Warrant, when
      countersigned by the Warrant Agent, may be exercised by the registered holder
      thereof by surrendering it, at the office of the Warrant Agent, or at the office
      of its successor as Warrant Agent, in the Borough of Manhattan, City and State
      of New York, with the exercise form, as set forth in the Warrant, duly completed
      and executed, and by paying in full, in lawful money of the United States,
      in
      cash or by certified check payable to the order of the Company (or as otherwise
      agreed by the Company), the Warrant Price for each full share of Common Stock
      as
      to which such Warrant is exercised, the aggregate exercise price for such
      Warrant to be rounded up to the next whole cent for such Warrant so exercised
      (for example, if a Warrant is exercised for 5 shares of Common Stock, the
      aggregate exercise price shall be $2.62, or $0.523 multiplied by 5 shares,
      rounded to the next whole cent) and any and all transfer taxes in respect of
      such Warrant or shares of Common Stock issuable on exercise thereof.

     

    3.3.2     Issuance
      of Certificates.
      As soon
      as practicable after the exercise of any Warrant and the clearance of the funds
      in payment of the Warrant Price in respect thereof, the Company shall issue
      or
      cause to be issued to the registered holder of such Warrant a certificate or
      certificates for the number of full shares of Common Stock to which it is
      entitled, registered in such name or names as may be directed by it, and if
      such
      Warrant shall not have been exercised in full, a new countersigned Warrant
      for
      the number of shares as to which such Warrant shall not have been exercised.
      

     

    3.3.3       Delivery
      of Securities.
      Notwithstanding anything contained herein to the contrary, the Company shall
      not
      be obligated to deliver any securities pursuant to the exercise of a Warrant
      unless a registration statement under the Securities Act with respect to the
      issuance of the securities that shall have been issuable upon such exercise
      is
      effective and, unless issuance of such securities is qualified or exempt from
      qualification under applicable securities laws of the states or other
      jurisdictions in which the registered holder of such Warrant resides. If such
      registration statement is not effective or the issuance of such securities
      is
      not exempt as described in the preceding sentence, the registered holder of
      such
      Warrant will not be entitled to exercise such Warrant and such Warrant may
      have
      no value and expire worthless. 

     

    3.3.4     No
      Net-Cash Settlement.
      Notwithstanding anything contained herein to the contrary, in no event shall
      the
      Company be liable for, or shall any registered holder of a Warrant be entitled
      to receive, (a) any net-cash settlement or other consideration in lieu of
      physical settlement in securities or (b) unless the conditions and requirements
      set forth in Sections 3.3.3 and 7.4 shall have been satisfied, physical
      settlement in securities upon exercise of any Warrant due to the inability
      to
      exercise any Warrant, or otherwise. 

     

    3.3.5     Valid
      Issuance.
      All
      shares of Common Stock issued upon the proper exercise of a Warrant in
      conformity with this Agreement shall be validly issued, fully paid and
      non-assessable.

     

    3.3.6     Date
      of Issuance.
      Each
      person in whose name any such certificate for shares of Common Stock is issued
      shall for all purposes be deemed to have become the holder of record of such
      shares on the date on which the Warrant was duly surrendered and payment of
      the
      Warrant Price was duly made, irrespective of the date of delivery of such
      certificate, except that, if the date of such surrender and payment is a date
      when the stock transfer books of the Company are closed, such person shall
      be
      deemed to have become the holder of record of such shares at the close of
      business on the next succeeding date on which the stock transfer books are
      open.

     

     

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

     

    4.     Adjustments..

     

    4.1.     Adjustment
      of Exercise Rate and Exercise Price.
      The
      number of shares of Common Stock purchasable upon the exercise of each Warrant
      (the “Exercise
      Rate”),
      and
      the Exercise Price, are subject to adjustment from time to time upon the
      occurrence of the events enumerated in this Section 4. The Exercise Rate shall
      initially be 1 to 1.

     

    4.1.1     Adjustment
      for Change in Common Stock.
      If,
      after the date hereof, the Company:

     

    (a)     pays
      a
      dividend or makes a distribution on shares of its Common Stock payable in shares
      of its Common Stock;

     

    (b)     subdivides
      or splits any of its outstanding shares of Common Stock into a greater number
      of
      shares; or

     

    (c)     combines
      any of its outstanding shares of Common Stock into a smaller number of
      shares,

     

    then
      the
      Exercise Rate in effect immediately prior to such action for each Warrant then
      outstanding shall be adjusted by multiplying the Exercise Rate in effect
      immediately prior to such action by a fraction (A) the numerator of which shall
      be the number of shares of Common Stock outstanding immediately after such
      action and (B) the denominator of which shall be the number of shares of Common
      Stock outstanding immediately prior to such action or the record date applicable
      to such action, if any (regardless of whether the Warrants then outstanding
      are
      then exercisable); and the Exercise Price for each Warrant shall be adjusted
      to
      a number determined by dividing the Exercise Price immediately prior to such
      event by such fraction. The $1.046 per
      share
      contained in Section 6.1 shall also be adjusted to a number determined by
      dividing the Exercise Price immediately prior to such event by such fraction.
      The adjustment shall become effective immediately after the record date in
      the
      case of a dividend or distribution and immediately after the effective date
      in
      the case of a subdivision, combination or reclassification. If such dividend
      or
      distribution is not so paid or made or such subdivision, combination or
      reclassification is not effected, the Exercise Rate and Exercise Price shall
      again be adjusted to be the Exercise Rate and Exercise Price which would then
      be
      in effect if such record date or effective date had not been so fixed.

    

    4.2.     Replacement
      of Securities upon Reorganization, Etc.
      In case
      of any reclassification (including, without limitation, a reclassification
      effected by means of an exchange or tender offer by the Company) or
      reorganization of the outstanding shares of Common Stock (other than a change
      that solely affects the par value of the Common Stock or as a result of a
      subdivision or combination covered by Section 4.1), or in the case of any merger
      or consolidation of the Company with or into another entity (other than a
      consolidation or merger in which the Company is the continuing corporation
      and
      that does not result in any reclassification or reorganization of the
      outstanding shares of Common Stock), or in the case of any sale or conveyance
      to
      another corporation or entity of the assets or other property of the Company
      as
      an entirety or substantially as an entirety in connection with which the Company
      is dissolved (each, a “Reorganization
      Event”),
      each
      registered holder shall have the right thereafter (until the expiration of
      the
      right to exercise his Warrant) to receive, in lieu of the shares of Common
      Stock
      immediately theretofore receivable upon the exercise of his Warrant, the kind
      and amount of shares of Common Stock and/or other securities and/or property
      (including cash) receivable upon such Reorganization Event that such registered
      holder would have received if he had exercised his Warrant immediately prior
      to
      such Reorganization Event. The provisions of this Section 4.2 shall similarly
      apply to successive Reorganization Events. In case of any Reorganization Event
      that is a consolidation or merger, the corporation formed by such consolidation
      or merger shall execute and deliver a supplemental Warrant Agreement
      acknowledging the provisions of this Section 4.2 and providing for adjustments
      that shall be as identical as practicable to the adjustments provided in this
      Section 4.

     

     

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

     

    4.3.     Certificate
      of Adjustment.
      After
      each adjustment of the Exercise Rate or the Exercise Price, the Company will
      promptly prepare a certificate signed by the Chief Executive Officer, President,
      Chief Financial Officer, Treasurer or Secretary of the Company setting forth:
      (a) the Exercise Rate and Exercise Price, as so adjusted; (b) the amount of
      shares of Common Stock purchasable upon exercise of each Warrant after such
      adjustment; and (c) a brief statement of the facts accounting for such
      adjustment. Such certificate shall be conclusive evidence that the adjustment
      is
      correct, absent manifest error and the Warrant Agent may rely conclusively
      on
      anything contained in this certificate. The Company will promptly cause a brief
      summary thereof to be filed with the Warrant Agent and either the Company or
      the
      Warrant Agent will send such summary by ordinary first class mail to each
      registered holder at such registered holder’s last address as it shall appear on
      the registry books of the Company, but the failure to give such notice (or
      any
      defect therein) shall not affect the legality or validity of such event.

     

    4.4.     No
      Fractional Shares.
      Notwithstanding any provision contained in this Agreement to the contrary,
      the
      Company shall not be required to issue fractional shares upon exercise of
      Warrants and shall not be required to issue scrip or pay cash in lieu of any
      fractional interests. If, by reason of any adjustment made pursuant to this
      Section 4, the registered holder of any Warrant would be entitled, upon the
      exercise of such Warrant, to receive a fractional share, the Company shall
      issue
      the nearest whole number of shares of Common Stock to such registered
      holder.

     

    4.5.     Changes
      in Form.
      The
      form of Warrant need not be changed because of any adjustment pursuant to this
      Section 4, and Warrants issued after such adjustment may state the same Warrant
      Price and the same number of shares of Common Stock issuable on exercise thereof
      as is stated in the Warrants initially issued pursuant to this Agreement. The
      acceptance by a registered holder of the issuance of a new Warrant reflecting
      a
      required or permissive change shall not be deemed to waive any rights to an
      adjustment occurring after the computation thereof. The Company may at any
      time
      in its sole discretion make any change in the form of Warrant that the Company
      may deem appropriate and that does not affect the substance thereof, and any
      Warrant thereafter issued or countersigned, whether in exchange or substitution
      for an outstanding Warrant, or otherwise, may be issued or countersigned in
      the
      form as so changed.

     

     

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

     

     

    5.     Transfer
      and Exchange of Warrants..

     

    5.1.     Registration
      of Transfer.
      The
      Warrant Agent shall register the transfer, from time to time, of any outstanding
      Warrant, upon the Warrant Register, upon surrender of such Warrant for transfer,
      properly endorsed with signatures properly guaranteed and accompanied by
      appropriate instructions for transfer in substantially in the form attached
      to
      the relevant Warrant Certificate, provided,
      however,
      that
      the Warrant Agent shall not register the transfer of any outstanding Warrant
      held by an affiliate (as defined under the Securities Act) until the Warrant
      Agent has received an opinion of counsel for the Company stating that such
      transfer may be made. From time to time, the Company shall deliver to the
      Warrant Agent a list of directors and executive officers of the Company and,
      to
      the extent known, a list of other affiliates of the Company. Any registered
      holder desiring to exchange or transfer a Warrant Certificate shall deliver
      a
      written request to the Warrant Agent at its principal office, which is currently
      located at the address listed in Section 9.2 hereof. When Warrant Certificates
      are presented to the Warrant Agent with a written request (a) to register the
      transfer of the Warrant Certificates or (b) to exchange such Warrants
      Certificates for an equal number of Warrant Certificates of other authorized
      denominations, the Warrant Agent shall register the transfer or make the
      exchange as requested if the Warrant Certificates so presented have been duly
      endorsed or accompanied by a written instruction of transfer in form
      satisfactory to the Warrant Agent, duly executed by the registered holder or
      by
      such registered holder’s attorney and if any other requirements of the Warrant
      Agent for such transactions are met; provided,
      however,
      that if
      a Warrant surrendered for transfer bears a restrictive legend, the Warrant
      Agent
      shall not cancel such Warrant and issue new Warrants in exchange therefor until
      the Warrant Agent has received an opinion of counsel for the Company stating
      that such transfer may be made and indicating whether the new Warrants must
      also
      bear a restrictive legend.

     

    5.2.     Surrender
      of Warrant Certificates.
      Any
      Warrant Certificate surrendered for registration of transfer, exchange, exercise
      or repurchase of the Warrants represented thereby, or in connection with a
      Conversion, shall, if surrendered to the Company, be delivered to the Warrant
      Agent, and all Warrant Certificates surrendered or so delivered to the Warrant
      Agent shall be promptly canceled by the Warrant Agent and shall not be reissued
      by the Company and, except as provided in this Section 5 in case of a transfer
      or exchange or in Section 3 in case of the exercise or repurchase of less than
      all the Warrants represented thereby or in case of a mutilated Warrant
      Certificate, no Warrant Certificate shall be issued hereunder in lieu thereof.
      All cancelled Warrant Certificates held by the Warrant Agent shall be disposed
      of by the Warrant Agent in accordance with its customary procedures and
      certification of their disposal will be delivered to the Company from time
      to
      time as the Company may direct in writing.

     

    5.3.     Fractional
      Warrants.
      The
      Warrant Agent shall not effect any registration of transfer or exchange which
      will result in the issuance of a fraction of a Warrant, except as required
      by
      the rules of any national securities exchange upon which the Company’s Common
      Stock may then be listed. 

     

     

    
      
         

      

      
        6

        
          

        

      

      
         

      

    

     

    5.4.     Service
      Charges.
      No
      service charge shall be made for any registration of exchange or transfer of
      Warrants.

     

    5.5.     Warrant
      Execution and Countersignature.
      The
      Warrant Agent is hereby authorized to countersign and to deliver, in accordance
      with the terms of this Agreement, the Warrants required to be issued pursuant
      to
      the provisions of this Section 5, and the Company, whenever required by the
      Warrant Agent, will supply the Warrant Agent with Warrants duly executed on
      behalf of the Company for such purpose.

     

     

    6.     Redemption.

     

    6.1.     Redemption.
      Not
      less than all of the outstanding Warrants may be called for redemption, at
      the
      option of the Company, at any time after November 4, 2007 and prior to their
      expiration, at the price of $.01 per Warrant (“Redemption
      Price”);
      provided,
      that
      Warrants shall not be called for redemption unless the last sales price of
      the
      Common Stock shall have been at least $1.046 per share on each of twenty (20)
      trading days within the thirty (30) trading day period ending on the third
      Business Day prior to the date on which notice of redemption is given. As used
      herein, the term “Business
      Day”
shall
      mean any day, except a Saturday, Sunday or legal holiday on which the banking
      institutions in the City of New York are authorized or obligated by law or
      executive order to close. 

     

    6.2.     Date
      Fixed for, and Notice of, Redemption.
      In the
      event the Company shall elect to redeem all of the Warrants, the Company shall
      fix a date for the redemption (the “Redemption
      Date”).
      Notice of redemption shall be mailed by first class mail, postage prepaid,
      by
      the Company not less than thirty (30) days prior to the date fixed for
      redemption to the registered holders of the Warrants at their last addresses
      as
      they shall appear on the Warrant Register. Any notice mailed in the manner
      herein provided shall be conclusively presumed to have been duly given, whether
      or not any registered holder shall have received such notice.

     

    6.3.     Exercise
      After Notice of Redemption.
      The
      Warrants may be exercised in accordance with Section 3 at any time after notice
      of redemption shall have been given by the Company pursuant to Section 6.2
      and
      prior to 5:00 p.m., New York time, on the Redemption Date. On and after the
      Redemption Date, the registered holder of Warrants shall have no further rights
      except to receive, upon surrender of such Warrants, the Redemption
      Price.

     

     

    7.     Other
      Provisions Relating to Rights of Holders of Warrants.

     

    7.1.     No
      Rights as Stockholder.
      A
      Warrant does not entitle the registered holder thereof to any of the rights
      of a
      stockholder of the Company, including, without limitation, the right to receive
      dividends or other distributions, to participate in any rights offering, to
      vote
      or consent, or to receive notice as a stockholder in respect of meetings of
      stockholders or election of directors of the Company or any other
      matter.

     

    7.2.     Lost,
      Stolen, Mutilated or Destroyed Warrants.
      If any
      Warrant is lost, stolen, mutilated or destroyed, the Company and the Warrant
      Agent may on such terms as to indemnity or otherwise as they may in their
      discretion impose (which shall, in the case of a mutilated Warrant, include
      the
      surrender thereof), issue a new Warrant of like denomination, tenor and date
      as
      the Warrant so lost, stolen, mutilated or destroyed. Any such new Warrant shall
      constitute a substitute contractual obligation of the Company, whether or not
      the allegedly lost, stolen, mutilated or destroyed Warrant shall be at any
      time
      enforceable by any person.

     

     

    
      
         

      

      
        7

        
          

        

      

      
         

      

    

     

    7.3.     Reservation
      of Common Stock.
      The
      Company shall at all times reserve and keep available a number of its authorized
      but unissued shares of Common Stock that will be sufficient to permit the
      exercise in full of all outstanding Warrants issued pursuant to this
      Agreement.

     

    7.4.     Registration
      of Common Stock.
      The
      Company agrees that, prior to the commencement of and during the Exercise
      Period, it shall use commercially reasonable efforts to file with the United
      States Securities and Exchange Commission (the “Commission”),
      a
      registration statement or any other filings with the Commission necessary to
      cause to become effective and to maintain the effectiveness of the registration
      under the Securities Act of the issuance of the Common Stock issuable upon
      exercise of the Warrants; provided,
      however,
      that in
      no event shall the Company be liable for, or shall any registered holder of
      a
      Warrant be entitled to receive, (a) any net-cash settlement or other
      consideration in lieu of physical settlement in securities or (b) unless the
      conditions and requirements set forth in Section 3.3.3 and this Section 7.4
      shall have been satisfied, physical settlement in securities upon exercise
      of
      any Warrant due to the inability to exercise any Warrant, or otherwise. The
      obligations of the Company under the preceding sentence shall terminate upon
      the
      expiration or redemption of the Warrants in accordance with the provisions
      of
      this Agreement (or, if the Company completes a going private transaction prior
      to such expiration or redemption, at such time as such transaction is
      completed). 

     

     

    8.     Concerning
      the Warrant Agent and Other Matters..

     

    8.1.     Payment
      of Taxes.
      The
      Company will from time to time promptly pay all applicable taxes and other
      governmental charges that may be imposed upon the Company or the Warrant Agent
      due in connection with the exercise of the Warrants and the issuance of the
      Common Stock upon the exercise of Warrants, but the Company shall not be
      obligated to pay any transfer taxes in respect of Warrants or such
      shares.

     

    8.2.     Resignation,
      Consolidation, or Merger of Warrant Agent. 

     

    8.2.1     Resignation
      or Removal.
      The
      Warrant Agent, or any successor to it, may resign its duties and be discharged
      from all further duties and liabilities hereunder after giving thirty (30)
      days'
      notice in writing to the Company, and the Company may remove the Warrant Agent
      at any time, without assigning any cause therefor, by delivering to the Warrant
      Agent written notice of removal, effective not less than thirty (30) days after
      receipt by the Warrant Agent of such notice. If the office of the Warrant Agent
      becomes vacant by resignation or removal or otherwise, the Company shall appoint
      in writing a successor Warrant Agent in place of the Warrant Agent. If the
      Company shall fail to make such appointment within a period of thirty (30)
      days
      after it has been notified in writing of such vacancy by the Warrant Agent
      or by
      the registered holder of any Warrant (who shall, with such notice, submit its
      Warrant for inspection by the Company), then any holder of any Warrant may
      apply
      to the Supreme Court of the State of New York for the County of New York for
      the
      appointment of a successor Warrant Agent at the Company's cost. Any successor
      Warrant Agent, whether appointed by the Company or by such court, shall be
      a
      national banking corporation or a corporation organized and existing under
      the
      laws of the State of New York, in good standing and having its principal office
      in the Borough of Manhattan, City and State of New York, and authorized under
      such laws to exercise corporate trust powers and subject to supervision or
      examination by federal or state authority. 

     

     

    
      
         

      

      
        8

        
          

        

      

      
         

      

    

     

    8.2.2     Successor
      Warrant Agent.
      After
      appointment, any successor Warrant Agent shall be vested with all the authority,
      powers, rights, immunities, duties and obligations of its predecessor Warrant
      Agent with like effect as if originally named as Warrant Agent hereunder,
      without any further act or deed; but if for any reason it becomes necessary
      or
      appropriate, the predecessor Warrant Agent shall execute and deliver, at the
      expense of the Company, an instrument transferring to such successor Warrant
      Agent all the authority, powers, and rights of such predecessor Warrant Agent
      hereunder; and upon request of any successor Warrant Agent the Company shall
      make, execute, acknowledge and deliver any and all instruments in writing for
      more fully and effectually vesting in and confirming to such successor Warrant
      Agent all such authority, powers, rights, immunities, duties and obligations.
      In
      addition, in the event of a resignation or removal, the property held by the
      Warrant Agent hereunder shall be duly transferred to the successor Warrant
      Agent. 

     

    8.2.3     Notice
      of Successor Warrant Agent.
      In the
      event a successor Warrant Agent shall be appointed, the Company shall give
      notice thereof to the predecessor Warrant Agent and the transfer agent for
      the
      Common Stock not later than the effective date of any such
      appointment.

     

    8.2.4     Merger
      or Consolidation of Warrant Agent.
      Any
      corporation into which the Warrant Agent may be merged or with which it may
      be
      consolidated or any corporation resulting from any merger or consolidation
      to
      which the Warrant Agent shall be a party shall be the successor Warrant Agent
      under this Agreement without any further act.

     

    8.3.     Fees
      and Expenses of Warrant Agent.

     

    8.3.1     Remuneration.
      The
      Company agrees to pay the Warrant Agent reasonable remuneration for its services
      as such Warrant Agent hereunder and will reimburse the Warrant Agent upon demand
      for all expenditures that the Warrant Agent may reasonably incur in the
      execution of its duties hereunder.

     

    8.3.2     Further
      Assurances.
      From
      time to time on and after the date hereof, the Company agrees to perform,
      execute, acknowledge and deliver or cause to be performed, executed,
      acknowledged and delivered all such further and other acts, instruments,
      documents and assurances as may reasonably be required by the Warrant Agent
      for
      the carrying out or performing of the provisions and purposes of this Agreement,
      to evidence compliance herewith or to assure itself that it is protected in
      acting hereunder.

     

     

    
      
         

      

      
        9

        
          

        

      

      
         

      

    

     

    8.4.     Liability
      of Warrant Agent

     

    8.4.1     Reliance
      on Company Statement.
      Whenever in the performance of its duties under this Agreement, the Warrant
      Agent shall deem it necessary or desirable that any fact or matter be proved
      or
      established by the Company prior to taking or suffering any action hereunder,
      such fact or matter (unless other evidence in respect thereof be herein
      specifically prescribed) may be deemed to be conclusively proved and established
      by a statement signed by the Chief Executive Officer, President, Chief Financial
      Officer or Chairman of the Board of the Company and delivered to the Warrant
      Agent. The Warrant Agent may rely upon such statement for any action taken
      or
      suffered in good faith by it pursuant to the provisions of this
      Agreement.

     

    8.4.2     Indemnity.
      The
      Warrant Agent shall be liable hereunder only for its own gross negligence,
      willful misconduct or bad faith. The Company agrees to indemnify the Warrant
      Agent and save it harmless against any and all liabilities, including judgments,
      costs and reasonable counsel fees, for anything done or omitted by the Warrant
      Agent in the execution of this Agreement except as a result of the Warrant
      Agent's gross negligence, willful misconduct or bad faith.

     

    8.4.3     Exclusions.
      The
      Warrant Agent shall have no responsibility with respect to the validity of
      this
      Agreement or with respect to the validity or execution of any Warrant (except
      its countersignature thereof); nor shall it be responsible for any breach by
      the
      Company of any covenant or condition contained in this Agreement or in any
      Warrant; nor shall it be responsible to make any adjustments required under
      the
      provisions of Section 4 or responsible for the manner, method or amount of
      any
      such adjustment or the ascertaining of the existence of facts that would require
      any such adjustment; nor shall it by any act hereunder be deemed to make any
      representation or warranty as to the authorization or reservation of any shares
      of Common Stock to be issued pursuant to this Agreement or any Warrant or as
      to
      whether any shares of Common Stock will when issued be valid and fully paid
      and
      non-assessable.

     

    8.5.     Acceptance
      of Agency.
      The
      Warrant Agent hereby accepts the agency established by this Agreement and agrees
      to perform the same upon the terms and conditions herein set forth and among
      other things, shall account promptly to the Company with respect to Warrants
      exercised and concurrently account for, and promptly pay to the Company, all
      moneys received by the Warrant Agent for the purchase of shares of Common Stock
      through the exercise of Warrants.

     

     

    9.     Miscellaneous
      Provisions..

     

    9.1.     Confidentiality.

     

    9.1.1     Confidential
      Information.
      Subject
      to Section 9.1.3, all information (whether in written, electronic, oral or
      other
      form and including trade secrets and non-public, confidential or proprietary
      information) received by the Warrant Agent or its agents, advisors or other
      representatives (individually and collectively, the “Receiving
      Party”)
      relating to (i) the other Party, its subsidiaries or affiliates or its or their
      agents, advisors or other representatives (individually and collectively, a
      “Disclosing
      Party”),
      or
      (ii) this Agreement or the transactions contemplated hereby, in each case,
      furnished by or on behalf of or obtained from a Disclosing Party, before or
      after the date hereof shall be treated as confidential (collectively, the
“Confidential
      Information”).

     

     

    
      
         

      

      
        10

        
          

        

      

      
         

      

    

     

    9.1.2     Use.
      The
      Receiving Party (i) will keep all of the Confidential Information confidential
      and will not disclose any of the Confidential Information in any manner
      whatsoever (except as required by applicable law) without the prior written
      consent of the relevant Disclosing Party, and (ii) will not use any of the
      Confidential Information in any manner whatsoever other than in connection
      with
      the consummation of the transactions contemplated hereby; provided,
      however,
      that
      Confidential Information may be revealed to agents, advisors or other
      representatives of the Receiving Party who (x) need to know such Confidential
      Information for the purpose of consummating such transactions, (y) are informed
      in writing by the Receiving Party of the confidential nature and restricted
      use
      of such Confidential Information and (z) agree to observe the terms of this
      Section 9.1 as if they were Parties. 

     

    9.1.3     Exclusions.
      Confidential Information shall not include information to the extent, but only
      to the extent, that such information is (i) on the date hereof part of, or
      after
      the date hereof becomes part of, the public domain other than as a result of
      disclosure by the Receiving Party or any of its agents, advisors or other
      representatives where such disclosure constituted or constitutes a breach of
      this Section 9.1, (ii) on the date hereof known by the Receiving Party or its
      agents, advisors or other representatives so long as such knowledge is
      demonstrated by reasonably convincing written (or, if dating is demonstrated
      by
      reasonably convincing evidence, electronic) evidence, (iii) after the date
      hereof becomes known by the Receiving Party on a non-confidential basis from
      a
      source (other than a Disclosing Party) which, to the knowledge of the Receiving
      Party, after due inquiry, is not prohibited from disclosing such information
      by
      a statutory, regulatory, contractual or fiduciary obligation or (iv) after
      the
      date hereof developed by the Receiving Party independent of any information
      furnished by or on behalf of or obtained from a Disclosing Party so long as
      such
      independent development is clearly and convincingly demonstrated by dated
      written (or, if dating can be independently demonstrated by reasonably
      convincing evidence, electronic) records of a type that is customarily generated
      and maintained by the Receiving Party in the ordinary course consistent with
      past practices. 

     

    9.2.     Notices.
      All
      notices and demands required or permitted to be given to a Party pursuant to
      this Agreement shall be transmitted by personal delivery, by a nationally
      recognized courier service, by registered or certified mail, return receipt
      requested, postage prepaid, or by facsimile and shall be addressed as
      follows:

     

    When
      the
      Company is the intended recipient:

     

    DOV
      Pharmaceutical, Inc.

    150
      Pierce Street

    Somerset,
      New Jersey 08873

    Attention:
      Chief Financial Officer

    Facsimile:
      (732) 907-3799

     

     

    
      
         

      

      
        11

        
          

        

      

      
         

      

    

     

    With
      a
      copy to:

     

    DOV
      Pharmaceutical, Inc.

    150
      Pierce Street

    Somerset,
      New Jersey 08873

    Attention:
      General Counsel

    Facsimile:
      (732) 907-3799

    

    When
      the
      Warrant Agent is the intended recipient:

     

    Continental
      Stock Transfer & Trust Company 

    17
      Battery Place

    New
      York,
      NY 10004

    Attention:
      Compliance Department 

    Facsimile:  (212)
      616-7616

     

    A
      Party
      may designate a new address to which notices required or permitted to be given
      pursuant to this Agreement shall thereafter be transmitted by giving written
      notice to that effect to the other Party. Each notice transmitted in the manner
      described in this Section 9.2 shall be deemed to have been given, received
      and
      become effective for all purposes at the time it shall have been (a) delivered
      to the addressee as indicated by the affidavit of the messenger (if transmitted
      by personal delivery), the receipt of the courier service (if transmitted by
      courier service), the return receipt (if transmitted by mail) or the answer
      back
      or call back (if transmitted by facsimile) or (b) presented for delivery to
      the
      addressee as so indicated during normal business hours, if such delivery shall
      have been refused for any reason.

     

    9.3.     Governing
      Law; Forum; Jury Trial.
      THE
      VALIDITY, INTERPRETATION, PERFORMANCE AND ENFORCEMENT OF THIS AGREEMENT SHALL
      BE
      GOVERNED BY THE LAWS OF THE STATE OF NEW YORK. Each Party agrees that any
      action, claim or proceeding arising out of this Agreement or the breach or
      threatened breach of this Agreement shall be commenced and prosecuted in a
      court
      in the State of New York. Each Party consents and submits to the non-exclusive
      personal jurisdiction of any court in the State of New York in
      respect of any such action, claim or proceeding. Each Party consents to service
      of process upon it with respect to any such action, claim or proceeding by
      registered mail, return receipt requested, and by any other means permitted
      by
      applicable laws. Each Party waives any objection that it may now or hereafter
      have to the laying of venue of any such action, claim or proceeding in any
      court
      in the State of New York and
      any
      claim that it may now or hereafter have that any such action, claim or
      proceeding in any court in the State of New York has
      been
      brought in an inconvenient forum. EACH PARTY WAIVES TRIAL BY JURY IN ANY SUCH
      ACTION, CLAIM OR PROCEEDING.

     

    9.4.     Binding
      Effect; Assignment; Third Party Beneficiaries.
      This
      Agreement shall be binding upon the Parties and their respective successors
      and
      assigns and shall inure to the benefit of the Parties and their respective
      successors and permitted assigns. Except as permitted in Section 8.2, neither
      Party shall assign any of its rights or delegate any of its duties under this
      Agreement (by operation of law or otherwise) without the prior written consent
      of the other Party. Any assignment of rights or delegation of duties under
      this
      Agreement by a Party without the prior written consent of the other Party,
      if
      such consent is required hereby, shall be void. No such assignment or delegation
      shall relieve the assignor or delegator of its obligations hereunder,
      except
      that if a Party delegates any of its obligations hereunder with the prior
      written consent of the other Party, then it shall be relieved of those
      obligations assumed by its delegatee. The Representative (as to Sections 6.1,
      7.4 and 9.2), the registered holders and any such transferee shall be deemed
      third party beneficiaries of this Agreement. Except as otherwise provided
      herein, no other person shall be, or be deemed to be, a third party beneficiary
      of this Agreement. 

     

     

    
      
         

      

      
        12

        
          

        

      

      
         

      

    

     

    9.5.     Entire
      Agreement.
      This
      Agreement constitutes the entire agreement between the Parties with respect
      to
      the subject matter hereof and cancels and supersedes all of the previous or
      contemporaneous agreements, representations, warranties and understandings
      (whether oral or written) by or between the Parties with respect to the subject
      matter hereof. 

     

    9.6.     Amendments.
      No
      addition to, and no cancellation, renewal, extension, modification
      or amendment of, this Agreement shall be binding upon a Party unless such
      addition, cancellation, renewal, extension, modification or amendment is set
      forth in a written instrument that states that it adds to, cancels, renews,
      extends, modifies
      or amends this Agreement and that is executed and delivered on behalf of each
      Party by an officer of, or attorney-in-fact for, such Party, or, if a natural
      person, by such Party or an attorney-in-fact for such Party, and each such
      cancellation, renewal, extension, modification or amendment shall be subject
      to
      the prior written consent of the Representative; provided,
      that
      notwithstanding the foregoing, this Agreement may be amended or supplemented
      without consent of the Warrant Agent or the Representative to (x) cure any
      ambiguity or omission or to correct or supplement any provision contained herein
      that may be defective or inconsistent with any other provision contained herein,
      (y) add further covenants, restrictions or conditions of the Company for the
      benefit of the Warrant Agent or the registered holders, or (z) make any other
      change that is not adverse to the Warrant Agent or the registered holders.
      

     

    9.7.     Waivers.
      No
      waiver of any provision of this Agreement shall be binding upon a Party, unless
      such waiver is expressly set forth in a written instrument that is executed
      and
      delivered by such Party. Such waiver shall be effective only to the extent
      specifically set forth in such written instrument. Neither the exercise (from
      time to time and at any time) by a Party of, nor the delay or failure (at any
      time or for any period of time) to exercise, any right, power or remedy shall
      constitute a waiver of the right to exercise, or impair, limit or restrict
      the
      exercise of, such right, power or remedy or any other right, power or remedy
      at
      any time and from time to time thereafter. No waiver of any right, power or
      remedy of a Party shall be deemed to be a waiver of any other right, power
      or
      remedy of such Party or shall, except to the extent so waived, impair, limit
      or
      restrict the exercise of such right, power or remedy.

     

    9.8.     Remedies
      Limited.
      Neither
      Party shall, for any reason or under any legal theory, be liable for any
      special, indirect, incidental or consequential damages arising out of any breach
      of or default under this Agreement, even if informed of the possibility of
      such
      damages in advance. 

     

    9.9.     Headings;
      Counterparts; Interpretation.

     

    9.9.1     Headings.
      The
      headings set forth herein have been inserted for convenience of reference only,
      shall not be considered a part of this Agreement and shall not limit, modify
      or
      affect in any way the meaning or interpretation of this Agreement.

     

     

    
      
         

      

      
        13

        
          

        

      

      
         

      

    

     

    9.9.2     Counterparts.
      This
      Agreement may be signed in any number of counterparts, each of which (when
      executed and delivered) shall constitute an original instrument, but all of
      which together shall constitute one and the same instrument. This Agreement
      shall become effective and be deemed to have been executed and delivered by
      all
      of the Parties at such time as counterparts shall have been executed and
      delivered by each of the Parties, regardless of whether each of the Parties
      has
      executed the same counterpart. It shall not be necessary when making proof
      of
      this Agreement to account for any counterparts other than a sufficient number
      of
      counterparts which, when taken together, contain signatures of all of the
      Parties. Delivery of a counterpart by facsimile shall be as effective as
      delivery of an original.

     

    9.9.3     Interpretation.
      Each of
      the Parties has participated substantially in the negotiation and drafting
      of
      this Agreement and no ambiguity herein shall be construed against the draftsman.
      

     

    9.10.     Severability.
      If any
      provision of this Agreement shall hereafter be held to be invalid, unenforceable
      or illegal, in whole or in part, in any jurisdiction under any circumstances
      for
      any reason, (a) such provision shall be reformed to the minimum extent necessary
      to cause such provision to be valid, enforceable and legal while preserving
      the
      intent of the Parties as expressed in, and the benefits to the Parties provided
      by, this Agreement or (b) if such provision cannot be so reformed, such
      provision shall be severed from this Agreement and an equitable adjustment
      shall
      be made to this Agreement (including addition of necessary further provisions
      to
      this Agreement) so as to give effect to the intent so expressed and the benefits
      so provided. Such holding shall not affect or impair the validity,
      enforceability or legality of such provision in any other jurisdiction or under
      any other circumstances. Neither such holding nor such reformation nor severance
      shall affect or impair the legality, validity or enforceability of any other
      provision of this Agreement.

     

    9.11.     Examination.
      A copy
      of this Agreement shall be available at all reasonable times at the office
      of
      the Warrant Agent for inspection by the registered holder of any Warrant. The
      Warrant Agent may require any such registered holder to submit its Warrant
      for
      inspection by it.

     

    [remainder
      of page intentionally left blank]

     

     

    

    
      
         

      

      
        14

        
          

        

      

      
         

      

    

     

    IN
      WITNESS WHEREOF,
      the
      Parties have executed and delivered this Agreement as of the date first above
      written.

     

    
      	 	 	 
	 	DOV
              PHARMACEUTICAL, INC.
	 
 	 
 	 
 
	 	By:  	/s/ Barbara
              Duncan
	 	
              

              Name:
                Barbara
                Duncan

            
	 	
              Title:
                Chief
                Executive Officer

            

    

    
      	 	 	 
	 	
              CONTINENTAL
                STOCK TRANSFER & TRUST
                COMPANY

            
	 
 	 
 	 
 
	Date: 	By:  	/s/ Roger
              Bernhammer
	 	
              

              Name:
                Roger Bernhammer

            
	 	
              Title:
                Vice President

            

    

     

     

     

     

    
      
         

      

      
        15

        
          

        

      

      
         

      

    

     

    Exhibit
      A

     

    [SPECIMEN
      WARRANT CERTIFICATE]

     

    
      	
              NUMBER
                W______

            	
              WARRANTS

            

    

     

    (THIS
      WARRANT WILL BE VOID IF NOT EXERCISED PRIOR TO 5:00 P.M.

    NEW
      YORK
      TIME, DECEMBER 31, 2009)

     

    DOV
      PHARMACEUTICAL, INC.

     

    CUSIP

     

    WARRANT

     

    THIS
      CERTIFIES THAT, for value received ,_____________________, is the registered
      holder (the “holder”)
      of
      ________________ Warrants, expiring at 5:00 p.m. New York time on December
      31,
      2009 and entitling the holder, upon exercise after the date specified in the
      immediately succeeding paragraph, to purchase one fully paid and non-assessable
      share of common stock, par value $0.0001 per share (the “Shares”),
      of
      DOV PHARMACEUTICAL, INC., a Delaware corporation (the “Company”),
      for
      each Warrant evidenced by this Warrant Certificate, at the price of $0.523
      per
      Share (the “Warrant
      Price”),
      upon
      surrender of this Warrant Certificate and payment of the Warrant Price at the
      office of the Warrant Agent identified below in accordance with the Warrant
      Agreement (as defined below; capitalized terms used without definition in this
      Warrant Certificate shall have the meanings given to them in the Warrant
      Agreement). 

     

    Each
      Warrant shall become exercisable on July 1, 2007, but subject to the third
      paragraph below regarding an effective registration statement under the
      Securities Act of 1933, as amended (the “Securities
      Act”).
      The
      Warrant Agreement provides that, upon the occurrence of certain events, the
      Warrant Price and the number of Shares purchasable upon exercise of a Warrant,
      may, subject to certain conditions, be adjusted.

     

    This
      Warrant Certificate and the Warrants evidenced hereby have been issued pursuant
      to the Warrant Agreement dated May 10, 2007 between the Company and Continental
      Stock Transfer & Trust Company, as Warrant Agent (the “Warrant
      Agreement”).
      Notwithstanding anything contained herein to the contrary, this Warrant
      Certificate and the Warrants evidenced hereby shall be governed by and be
      subject to the conditions, limitations and provisions set forth in the Warrant
      Agreement. 

     

    Prior
      to
      the commencement of and during the Exercise Period, the Company must use
      commercially reasonable efforts to file with the Commission, a registration
      statement or any other filings with the Commission necessary to cause to become
      effective and to maintain the effectiveness of the registration under the
      Securities Act of the issuance of the Common Stock issuable upon exercise of
      any
      Warrant evidenced by this Warrant Certificate, which obligations will terminate
      upon the expiration or redemption thereof in accordance with the provisions
      of
      the Warrant Agreement (or, if the Company completes a going private transaction
      prior to such expiration or redemption, at such time as such transaction is
      completed). 

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    The
      Company shall not be obligated to deliver any securities pursuant to the
      exercise of any Warrant evidenced by this Warrant Certificate unless a
      registration statement under the Securities Act with respect to the issuance
      of
      the securities that shall have been issuable upon such exercise is effective
      and
      unless issuance of such securities is qualified or exempt from qualification
      under applicable securities laws of the states or other jurisdictions in which
      the registered holder of the Warrant evidenced by this Warrant Certificate
      resides. If such registration statement is not effective or the issuance of
      such
      securities is not exempt as described in the preceding sentence, the registered
      holder of such Warrant will not be entitled to exercise such Warrant and such
      Warrant may have no value and expire worthless. In no event shall the Company
      be
      liable for, nor shall any registered holder of Warrants be entitled to receive,
      (a) any net-cash settlement or other consideration in lieu of physical
      settlement in securities or (b) unless the conditions and requirements set
      forth
      in Sections 3.3.3 and 7.4 of the Warrant Agreement shall have been satisfied,
      physical settlement in securities upon exercise of any Warrant due to the
      inability to exercise any Warrant, or otherwise. Except with respect to the
      right to receive the Redemption Price (as set forth in Section 6 of the Warrant
      Agreement), each Warrant not exercised on or before the Expiration Date will
      become void, and all rights thereunder and all rights in respect thereof under
      the Warrant Agreement will expire. 

     

    No
      fraction of a Share will be issued upon any exercise of a Warrant. If, upon
      exercise of a Warrant, the holder would be entitled to receive a fractional
      Share, the Company will, upon exercise, issue that number of Shares obtained
      by
      rounding such fractional share to the nearest whole number.

     

    Upon
      exercise of less than the total number of Warrants evidenced by this Warrant
      Certificate, the Warrant Agent shall issue to the holder a new Warrant
      Certificate of like tenor and evidencing the number of Warrants not so
      exercised.

     

    Upon
      due
      presentment for exchange or transfer of this Warrant Certificate at the office
      of the Warrant Agent, a new Warrant Certificate or Warrant Certificates of
      like
      tenor and evidencing in the aggregate a like number of Warrants shall be issued
      to the holder or transferee, as applicable, subject to the limitations set
      forth
      in the Warrant Agreement, without charge except for any applicable transfer
      tax.

     

    The
      Company and the Warrant Agent may deem and treat the registered holder as the
      absolute owner of this Warrant Certificate and the Warrants evidenced hereby
      (notwithstanding any notation of ownership or other writing hereon made by
      anyone other than the Company or the Warrant Agent), for the purpose of any
      exercise hereof and for all other purposes, and neither the Company nor the
      Warrant Agent shall be affected by any notice to the contrary.

     

    Neither
      this Warrant Certificate nor any of the Warrants evidenced hereby entitle the
      holder to any of the rights of a stockholder of the Company.

     

    THE
      COMPANY MAY REDEEM THE WARRANTS, IN WHOLE AND NOT IN PART, AT A PRICE OF $.01
      PER WARRANT AT ANY TIME AFTER NOVEMBER 4, 2007, BY GIVING 30 DAYS’ PRIOR WRITTEN
      NOTICE OF REDEMPTION, IF, AND ONLY IF, THE LAST SALES PRICE OF THE COMMON STOCK
      HAS BEEN AT LEAST $1.046 PER SHARE (THE “REDEMPTION PRICE”), ON EACH OF TWENTY
      (20) TRADING DAYS WITHIN THE THIRTY (30) TRADING DAY PERIOD ENDING ON THE THIRD
      BUSINESS DAY PRIOR TO THE DATE ON WHICH NOTICE OF REDEMPTION IS GIVEN. THE
      RIGHT
      TO EXERCISE THE WARRANTS WILL BE FORFEITED UNLESS THEY ARE EXERCISED BEFORE
      THE
      DATE SPECIFIED IN THE NOTICE OF REDEMPTION. ON AND AFTER THE REDEMPTION DATE,
      THE RECORD HOLDER OF A WARRANT WILL HAVE NO FURTHER RIGHTS EXCEPT TO RECEIVE,
      UPON SURRENDER OF THE WARRANTS, THE REDEMPTION PRICE. THE WARRANT AGREEMENT
      PROVIDES THAT, UPON THE OCCURRENCE OF CERTAIN EVENTS, THE $1.046 MINIMUM LAST
      SALES PRICE AT WHICH THE WARRANTS BECOME SUBJECT TO REDEMPTION, MAY, SUBJECT
      TO
      CERTAIN CONDITIONS, BE ADJUSTED.

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

     This
      certificate is not valid unless countersigned and registered by the Warrant
      Agent. 

     

     WITNESS
      the
      facsimile seal of the Corporation and the facsimile signatures of its duly
      authorized officers.

     

     

    
      	
              By:

            	
               

            	 	
              By:

            	
               

            
	
            	
              Chief
                Executive Officer

            	 	
            	
              President

            
	 	 	 	 	 
	 	 	 	 	
              CONTINENTAL
                STOCK TRANSFER & TRUST
                COMPANY 

            
	 	 	 	 	 
	 	 	 	
              By:

            	
            
	 	 	 	 	
              Name:

            
	 	 	 	 	Title: 

    

     

    The
      following abbreviations, when used in the inscription on the face of this
      certificate, shall be construed as though they were written out in full
      according to applicable laws or regulations:

     

    
      	
              TEN
                COM

            	
              -
                as tenants in common

            
	
              TEN
                ENT

            	
              -
                as tenants by the entireties

            
	
              JT
                TEN

            	
              -
                as joint tenants with right of survivorship and not as tenants in
                common

            
	 	
            

    

     

    
      
        
          	
                  UNIF
                    GIFT MIN ACT -

                	 	as
                  Custodian for 
	 	 	 
	
                  (Cust)

                	
                	
                  (Minor)

                
	
                  under Uniform Gifts to Minors Act of 

                	 	(state)

        

    

     

    Additional
      abbreviations may also be used though not in the above list.

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    EXERCISE
      FORM

    To
      Be
      Executed by the Holder in Order to Exercise Warrants

     

    The
      undersigned holder, _______________, hereby irrevocably elects to exercise
      ______________________ (_________) Warrants evidenced by this Warrant
      Certificate, and to purchase the shares of Common Stock issuable upon the
      exercise of such Warrants, and requests that certificates for such shares be
      issued in the name of and be delivered to

     

    
      	 	 
	 	 
	 	 
	 	 
	 	 
	(PLEASE PRINT OR TYPEWRITE
              NAME
              AND ADDRESS, INCLUDING ZIP CODE, AND INSERT SOCIAL SECURITY OR OTHER
              IDENTIFYING NUMBER OF ASSIGNEE) 
	                                     (                   
              )	
            

     

     

    and,
      if
      such number of Warrants shall not be all the Warrants evidenced by this Warrant
      Certificate, requests that a new Warrant Certificate of like tenor for the
      balance of such Warrants be registered in the name of, and delivered to, the
      holder at the address stated below.

     

     

    
      	 
	
              (Signature)

            

    

     

    NOTICE:
      The signature to this form must correspond with the name as written upon the
      face of the certificate in every particular, without alteration or enlargement
      or any change whatever.

     

    
      (Dated)

    

     

    
      	 
	 
	 
	
              (Signature
                Guaranteed)

            

    

     

    THE
      SIGNATURE SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS,
      STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP
      IN
      AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO SEC RULE
      17Ad-15).

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

     

     

    ASSIGNMENT
      FORM

    To
      Be
      Executed by the Holder in Order to Transfer Warrants

     

    For
      value
      received, the undersigned holder, _________________________________, hereby
      sells, assigns and transfers unto 

     

    
      	 	 
	 	 
	 	 
	 	 
	 	 
	(PLEASE PRINT OR TYPEWRITE
              NAME
              AND ADDRESS, INCLUDING ZIP CODE, AND INSERT SOCIAL SECURITY OR OTHER
              IDENTIFYING NUMBER OF ASSIGNEE) 
	                                     (                   
              )

    

     

    Warrants
      represented by the within Warrant Certificate, and does hereby irrevocably
      constitute and appoint 

     

    ______________________________________
      Attorney to transfer the said Warrants on the books of the within-named
      Corporation and Warrant Agent with full power of substitution in the
      premises.

     

    
       

      
        	 
	
                (Signature)

              

      

       

      NOTICE:
        The signature to this form must correspond with the name as written upon
        the
        face of the certificate in every particular, without alteration or enlargement
        or any change whatever.

       

      
        (Dated)

      

       

      
        	 
	 
	 
	
                (Signature
                  Guaranteed)

              

      

    

     

     

    THE
      SIGNATURE SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS,
      STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP
      IN
      AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO SEC RULE
      17Ad-15).

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00123-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00123-of-00352.parquet"}]]